Direkt zum Inhalt
Merck

Disrupting proton dynamics and energy metabolism for cancer therapy.

Nature reviews. Cancer (2013-08-24)
Scott K Parks, Johanna Chiche, Jacques Pouysségur
ZUSAMMENFASSUNG

Intense interest in the 'Warburg effect' has been revived by the discovery that hypoxia-inducible factor 1 (HIF1) reprogrammes pyruvate oxidation to lactic acid conversion; lactic acid is the end product of fermentative glycolysis. The most aggressive and invasive cancers, which are often hypoxic, rely on exacerbated glycolysis to meet the increased demand for ATP and biosynthetic precursors and also rely on robust pH-regulating systems to combat the excessive generation of lactic and carbonic acids. In this Review, we present the key pH-regulating systems and synthesize recent advances in strategies that combine the disruption of pH control with bioenergetic mechanisms. We discuss the possibility of exploiting, in rapidly growing tumours, acute cell death by 'metabolic catastrophe'.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Carboanhydrase aus Rindererythrocyten, lyophilized powder, ≥2,000 W-A units/mg protein
Sigma-Aldrich
Carboanhydrase aus Rindererythrocyten, ≥95% (SDS-PAGE), specific activity ≥3,500 W-A units/mg protein, lyophilized powder
Sigma-Aldrich
Carboanhydrase aus Rindererythrocyten, BioReagent, suitable for GFC marker
Sigma-Aldrich
Karbonanhydraseisozym II aus Rindererythrocyten, lyophilized powder, ≥3,000 W-A units/mg protein
Sigma-Aldrich
Carboanhydrase aus Rindererythrocyten, For use as a marker in SDS-PAGE
Sigma-Aldrich
Kohlensäureanhydrase I aus Humanerythrocyten
Sigma-Aldrich
Carbonic Anhydrase Isozyme II human, ≥80%, powder, ≥3,000 W-A units/mg protein
Sigma-Aldrich
Carboanhydrase aus Rindererythrocyten, non-denaturing PAGE marker
Supelco
Kohlensäureanhydrase I aus Humanerythrocyten, Isoelectric focusing marker, pI 6.6
Sigma-Aldrich
Karbonanhydraseisozym II aus Rindererythrocyten, Isoelectric focusing marker, pI 5.4
Sigma-Aldrich
Karbonanhydraseisozym II aus Rindererythrocyten, lyophilized powder, ≥2,000 W-A units/mg protein